Jeff Elkins

Jeff Elkins is the CEO of InterVene. Jeff has over 25 years of experience in the medical device industry, including stints as the President & CEO of FlowMedica Inc., Vice President & Business Unit Manager at Medtronic Corp, and Sr. Manager Operations at Cordis Endovenous Systems Inc.

Elkins joined InterVene in December 2018 as Chief Operating Officer, before being promoted to President & CEO in May 2020. Prior to InterVene, they were the President & CEO of Veniti Endovenous Therapies, which was acquired by Boston Scientific in July 2015.

Elkins has a Bachelor's degree in Mechanical Engineering from the University of Florida and a Master's degree in Business Administration from Pepperdine University.

Jeff Elkins studied mechanical engineering at the University of Massachusetts Amherst, where they earned a Bachelor of Science degree.

Some direct reports include Tracy Roberts - VP, Clinical Affairs, Mark Smutka - Consultant, Regulatory Affairs, and Eric Dooley - VP, Quality Assurance.